{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:04:29Z","timestamp":1771650269496,"version":"3.50.1"},"reference-count":50,"publisher":"Tottori University Faculty of Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Yonago Acta Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.33160\/yam.2026.02.015","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T22:08:36Z","timestamp":1771452516000},"page":"105-118","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019"],"prefix":"10.33160","volume":"69","author":[{"given":"Kyosuke","family":"Nagamizu","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Pathobiological Science and Technology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago 683-8503 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Laboratory, Tottori University Hospital, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Morishita","sequence":"additional","affiliation":[{"name":"Division of Clinical Laboratory, Tottori University Hospital, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u2019arif Athok","family":"Shofiudin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensaku","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Kitaura","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University, Yonago 683-8503 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Chikumi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18656","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523-34. PMID:27344959, DOI:10.1038\/nrmicro.2016.81","DOI":"10.1038\/nrmicro.2016.81"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020;27:992-1000.e3. PMID:32320677, DOI:10.1016\/j.chom.2020.04.009","DOI":"10.1016\/j.chom.2020.04.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13. PMID:32007143, DOI:10.1016\/S0140-6736(20)30211-7","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. PMID:31986264, DOI:10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Boneva E, Shivarov V, Ivanova M. A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer. Immuno. 2025;5:9. DOI:10.3390\/immuno5010009","DOI":"10.3390\/immuno5010009"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Lanier LL. NKG2D Receptor and Its Ligands in Host Defense. Cancer Immunol Res. 2015;3:575-82. PMID:26041808, DOI:10.1158\/2326-6066.CIR-15-0098","DOI":"10.1158\/2326-6066.CIR-15-0098"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Zingoni A, Molfetta R, Fionda C, Soriani A, Paolini R, Cippitelli M, et al. NKG2D and Its Ligands: \u201cOne for All, All for One\u201d. Front Immunol. 2018;9:476. PMID:29662484, DOI:10.3389\/fimmu.2018.00476","DOI":"10.3389\/fimmu.2018.00476"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Cai L, Li Y, Tan J, Xu L, Li Y. Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J Hematol Oncol. 2023;16:101. PMID:37670328, DOI:10.1186\/s13045-023-01499-1","DOI":"10.1186\/s13045-023-01499-1"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Hasan MF, Campbell AR, Croom-Perez TJ, Oyer JL, Dieffenthaller TA, Robles-Carrillo LD, et al. Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies. J Immunother Cancer. 2023;11:e007502. PMID:38081778, DOI:10.1136\/jitc-2023-007502","DOI":"10.1136\/jitc-2023-007502"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Baugh R, Khalique H, Seymour LW. Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response. Cancers (Basel). 2020;12:3827. PMID:33352921, DOI:10.3390\/cancers12123827","DOI":"10.3390\/cancers12123827"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Waldhauer I, Goehlsdorf D, Gieseke F, Weinschenk T, Wittenbrink M, Ludwig A, et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 2008;68:6368-76. PMID:18676862, DOI:10.1158\/0008-5472.CAN-07-6768","DOI":"10.1158\/0008-5472.CAN-07-6768"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Scand J Immunol. 2013;78:120-9. PMID:23679194, DOI:10.1111\/sji.12072","DOI":"10.1111\/sji.12072"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Baraga\u00f1o Raneros A, Suarez \u00c1lvarez B, L\u00f3pez Larrea C. Secretory pathways generating immunosuppressive NKG2D ligands: new targets for therapeutic intervention. OncoImmunology. 2014;3:e28497. PMID:25050215, DOI:10.4161\/onci.28497","DOI":"10.4161\/onci.28497"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun. 2006;346:175-81. PMID:16750166, DOI:10.1016\/j.bbrc.2006.05.092","DOI":"10.1016\/j.bbrc.2006.05.092"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Dassa L, Seidel E, Oiknine-Djian E, Yamin R, Wolf DG, Le-Trilling VTK, et al. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack. J Virol. 2018;92:e00162-18. PMID:29950412, DOI:10.1128\/JVI.00162-18","DOI":"10.1128\/JVI.00162-18"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Schepis D, D\u2019Amato M, Studahl M, Bergstr\u00f6m T, K\u00e4rre K, Berg L. Herpes simplex virus infection downmodulates NKG2D ligand expression. Scand J Immunol. 2009;69:429-36. PMID:19508374, DOI:10.1111\/j.1365-3083.2009.02241.x","DOI":"10.1111\/j.1365-3083.2009.02241.x"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Kofod-Olsen E, Ross-Hansen K, Schleimann MH, Jensen DK, M\u00f8ller JML, Bundgaard B, et al. U20 is responsible for human herpesvirus 6B inhibition of tumor necrosis factor receptor-dependent signaling and apoptosis. J Virol. 2012;86:11483-92. PMID:22896603, DOI:10.1128\/JVI.00847-12","DOI":"10.1128\/JVI.00847-12"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Schmiedel D, Tai J, Levi-Schaffer F, Dovrat S, Mandelboim O. Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells. J Virol. 2016;90:9608-17. PMID:27535049, DOI:10.1128\/JVI.01164-16","DOI":"10.1128\/JVI.01164-16"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Chaouat AE, Seliger B, Mandelboim O, Schmiedel D. The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition. Front Immunol. 2021;12:714799. PMID:34721381, DOI:10.3389\/fimmu.2021.714799","DOI":"10.3389\/fimmu.2021.714799"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Seidel E, Dassa L, Schuler C, Oiknine-Djian E, Wolf DG, Le-Trilling VTK, et al. The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing. PLoS Pathog. 2021;17:e1008807. PMID:33939764, DOI:10.1371\/journal.ppat.1008807","DOI":"10.1371\/journal.ppat.1008807"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Guan Y, Li W, Hou Z, Han Q, Lan P, Zhang J, et al. HBV suppresses expression of MICA\/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillance. Oncotarget. 2016;7:56107-19. PMID:27528231, DOI:10.18632\/oncotarget.11271","DOI":"10.18632\/oncotarget.11271"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Koutsakos M, McWilliam HEG, Aktepe TE, Fritzlar S, Illing PT, Mifsud NA, et al. Downregulation of MHC Class I Expression by Influenza A and B Viruses. Front Immunol. 2019;10:1158. PMID:31191533, DOI:10.3389\/fimmu.2019.01158","DOI":"10.3389\/fimmu.2019.01158"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Fern\u00e1ndez-Soto D, Garc\u00eda-Jim\u00e9nez \u00c1F, Casasnovas JM, Val\u00e9s-G\u00f3mez M, Reyburn HT. Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease. Front Immunol. 2024;15:1273942. PMID:38410511, DOI:10.3389\/fimmu.2024.1273942","DOI":"10.3389\/fimmu.2024.1273942"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Farzad F, Yaghoubi N, Azad FJ, Mahmoudi M, Mohammadi M. Prognostic Value of Serum MICA Levels as a Marker of Severity in COVID-19 Patients. Immunol Invest. 2021. PMID:35481955","DOI":"10.21203\/rs.3.rs-458280\/v1"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Nishikawa Y, Yamaguchi K, Shofiudin MA, Mimura M, Takata M, Mihara S, et al. Distinct immunity dynamics of natural killer cells in mild and moderate COVID-19 cases during the Omicron variant phase. Front Immunol. 2025;16:1594296. PMID:40421029, DOI:10.3389\/fimmu.2025.1594296","DOI":"10.3389\/fimmu.2025.1594296"},{"key":"26","unstructured":"26. Watanabe TUY, Satou N, Horiuchi Y, Tanaka M, Hayashibara K. The results of screening tests and whole-genome analyses for SARS-CoV-2 variants in Tottori, Japan. 2023."},{"key":"27","unstructured":"27. .Infection Control Measures Center DoHaW, Tottori Prefecture. Verification report of COVID-19 in Tottori Prefecture. 2024."},{"key":"28","unstructured":"28. Welfare MoHaLa. COVID-19 clinical practice guideline (2024). 2024."},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, et al. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol. 2008;9:1065-73. PMID:18677316, DOI:10.1038\/ni.1642","DOI":"10.1038\/ni.1642"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Esteso G, Luz\u00f3n E, Sarmiento E, G\u00f3mez-Caro R, Steinle A, Murphy G, et al. Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICA. J Immunol. 2014;193:1344-52. PMID:24973455, DOI:10.4049\/jimmunol.1303441","DOI":"10.4049\/jimmunol.1303441"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Bennett NJ, Ashiru O, Morgan FJE, Pang Y, Okecha G, Eagle RA, et al. Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. J Immunol. 2010;185:1093-102. PMID:20530255, DOI:10.4049\/jimmunol.1000789","DOI":"10.4049\/jimmunol.1000789"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Seidel E, Le VTK, Bar-On Y, Tsukerman P, Enk J, Yamin R, et al. Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA\u2217008 to Escape Elimination by NK Cells. Cell Rep. 2015;10:968-82. PMID:25683719, DOI:10.1016\/j.celrep.2015.01.029","DOI":"10.1016\/j.celrep.2015.01.029"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Fielding CA, Aicheler R, Stanton RJ, Wang ECY, Han S, Seirafian S, et al. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog. 2014;10:e1004058. PMID:24787765, DOI:10.1371\/journal.ppat.1004058","DOI":"10.1371\/journal.ppat.1004058"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419:734-8. PMID:12384702, DOI:10.1038\/nature01112","DOI":"10.1038\/nature01112"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Hilpert J, Grosse-Hovest L, Gr\u00fcnebach F, Buechele C, Nuebling T, Raum T, et al. Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J Immunol. 2012;189:1360-71. PMID:22730533, DOI:10.4049\/jimmunol.1200796","DOI":"10.4049\/jimmunol.1200796"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yamaguchi K, Chikumi H, Shimizu A, Takata M, Kinoshita N, Hashimoto K, et al. Diagnostic and prognostic impact of serum\u2010soluble UL 16\u2010binding protein 2 in lung cancer patients. Cancer Sci. 2012;103:1405-13. PMID:22587355, DOI:10.1111\/j.1349-7006.2012.02330.x","DOI":"10.1111\/j.1349-7006.2012.02330.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Seller A, Tegeler CM, Mauermann J, Schreiber T, Hagelstein I, Liebel K, et al. Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. Int J Mol Sci. 2024;25:4126. PMID:38612935, DOI:10.3390\/ijms25074126","DOI":"10.3390\/ijms25074126"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Tan G, Spillane KM, Maher J. The Role and Regulation of the NKG2D\/NKG2D Ligand System in Cancer. Biology (Basel). 2023;12:1079. PMID:37626965, DOI:10.3390\/biology12081079","DOI":"10.3390\/biology12081079"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Furukawa H, Oka S, Shimada K, Masuo K, Nakajima F, Funano S, et al. Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class l-Related Chain a (MICA) as Markers of ILD. Biomark Insights. 2015;10:BMI.S28209. PMID:26327779, DOI:10.4137\/BMI.S28209","DOI":"10.4137\/BMI.S28209"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Cui TX, Brady AE, Zhang YJ, Anderson C, Popova AP. IL-17a-producing \u03b3\u03b4T cells and NKG2D signaling mediate bacterial endotoxin-induced neonatal lung injury: implications for bronchopulmonary dysplasia. Front Immunol. 2023;14:1156842. PMID:37744375, DOI:10.3389\/fimmu.2023.1156842","DOI":"10.3389\/fimmu.2023.1156842"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Calabrese DR, Aminian E, Mallavia B, Liu F, Cleary SJ, Aguilar OA, et al. Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury. J Clin Invest. 2021;131:e137047. PMID:33290276, DOI:10.1172\/JCI137047","DOI":"10.1172\/JCI137047"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Hartmann JA, Cardoso MR, Talarico MCR, Kenney DJ, Leone MR, Reese DC, et al. Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses. Cell. 2024;187:2393-2410.e14. PMID:38653235, DOI:10.1016\/j.cell.2024.03.026","DOI":"10.1016\/j.cell.2024.03.026"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Fern\u00e1ndez-Messina L, Ashiru O, Ag\u00fcera-Gonz\u00e1lez S, Reyburn HT, Val\u00e9s-G\u00f3mez M. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells. J Cell Sci. 2011;124:321-7. PMID:21224393, DOI:10.1242\/jcs.076042","DOI":"10.1242\/jcs.076042"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122-7. PMID:35271343, DOI:10.1126\/science.abm8108","DOI":"10.1126\/science.abm8108"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Mangoni AA, Zinellu A. Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis. Front Immunol. 2023;14:1212998. PMID:37415980, DOI:10.3389\/fimmu.2023.1212998","DOI":"10.3389\/fimmu.2023.1212998"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Scheller J, Chalaris A, Garbers C, Rose-John S. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol. 2011;32:380-7. PMID:21752713, DOI:10.1016\/j.it.2011.05.005","DOI":"10.1016\/j.it.2011.05.005"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Ashiru O, Boutet P, Fern\u00e1ndez-Messina L, Ag\u00fcera-Gonz\u00e1lez S, Skepper JN, Val\u00e9s-G\u00f3mez M, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 2010;70:481-9. PMID:20068167, DOI:10.1158\/0008-5472.CAN-09-1688","DOI":"10.1158\/0008-5472.CAN-09-1688"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Greenhalgh T, Sivan M, Perlowski A, Nikolich J\u017d. Long COVID: a clinical update. Lancet. 2024;404:707-24. PMID:39096925, DOI:10.1016\/S0140-6736(24)01136-X","DOI":"10.1016\/S0140-6736(24)01136-X"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Tsao T, Buck AM, Grimbert L, LaFranchi BH, Altamirano Poblano B, Fehrman EA, et al. Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes. J Clin Invest. 2024;135:135. PMID:39688913","DOI":"10.1172\/JCI188182"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Fl\u00fch C, Chitadze G, Synowitz M, Mehdorn H, Held-Feindt J, Kabelitz D. P04.02 NKG2D-system in Glioblastoma patients and effect of radiochemo-therapy. Neuro-oncol. 2016;18(suppl 4):iv24. DOI:10.1093\/neuonc\/now188.080","DOI":"10.1093\/neuonc\/now188.080"}],"container-title":["Yonago Acta Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/69\/1\/69_2026.02.015\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:10:49Z","timestamp":1771647049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yam\/69\/1\/69_2026.02.015\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.33160\/yam.2026.02.015","relation":{},"ISSN":["1346-8049"],"issn-type":[{"value":"1346-8049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026.02.015"}}